Although there are a wide variety of drugs that are currently used in the treatment of HF, most notably angiotensin receptor blockers, angiotensin‐converting enzyme inhibitors, beta blockers and mineralocorticoid receptor antagonists [1], none of these drugs can actually reverse HF or the physiological remodelling of the heart associated with HF. The gene discussed is ACE; the disease is hydrops fetalis.